Why is Zenith Drugs falling/rising?

As of 13-Aug, Zenith Drugs Ltd is experiencing a decline in its stock price, currently at 63.30, which reflects a decrease of 0.7 or 1.09%. The stock has underperformed its sector today by 2.58%, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 6.01%, and it has seen a significant decline of 21.66% year-to-date, indicating a persistent downward trend without any available positive or negative factors to counterbalance this performance.
In the broader market context, while Zenith Drugs has faced a substantial decline, the Sensex has shown a slight increase of 0.18% over the past week and a 4.12% rise year-to-date. This contrast highlights that Zenith Drugs is not only underperforming against its sector but also lagging behind the overall market performance. The stock's negative returns over various periods, combined with its current trading position, suggest a challenging environment for investors in Zenith Drugs Ltd.